IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Sitagliptin prevent the onset of diabetic gastroparesis?
Sitagliptin has not been directly proven to prevent diabetic gastroparesis. It primarily works by regulating blood sugar levels in type 2 diabetes.
Sitagliptin has not been directly proven to prevent diabetic gastroparesis. It primarily works by regulating blood sugar levels in type 2 diabetes.
See lessCan Sitagliptin improve the efficacy of GLP-1 receptor agonists in therapy?
Sitagliptin, a DPP-4 inhibitor, may enhance GLP-1 levels, potentially improving the efficacy of GLP-1 receptor agonists in managing type 2 diabetes.
Sitagliptin, a DPP-4 inhibitor, may enhance GLP-1 levels, potentially improving the efficacy of GLP-1 receptor agonists in managing type 2 diabetes.
See lessCan Sitagliptin prevent beta-cell apoptosis in early diabetes?
Sitagliptin may help prevent beta-cell apoptosis by inhibiting DPP-4, enhancing GLP-1 activity, which improves beta-cell survival and function in early diabetes.
Sitagliptin may help prevent beta-cell apoptosis by inhibiting DPP-4, enhancing GLP-1 activity, which improves beta-cell survival and function in early diabetes.
See lessHow does Sitagliptin interact with anti-inflammatory therapies in diabetes?
Sitagliptin, a DPP-4 inhibitor used in type 2 diabetes, does not have proven synergistic anti-inflammatory effects when combined with anti-inflammatory therapies.
Sitagliptin, a DPP-4 inhibitor used in type 2 diabetes, does not have proven synergistic anti-inflammatory effects when combined with anti-inflammatory therapies.
See lessHow does Sitagliptin affect hepatic glucose output during fasting?
Sitagliptin reduces hepatic glucose production by inhibiting DPP-4, which enhances the incretin effect, improving fasting glucose levels in type 2 diabetes.
Sitagliptin reduces hepatic glucose production by inhibiting DPP-4, which enhances the incretin effect, improving fasting glucose levels in type 2 diabetes.
See lessHow does Sitagliptin impact the development of diabetes-related kidney diseases?
Sitagliptin, a DPP-4 inhibitor, may slow the progression of diabetic nephropathy by reducing albuminuria and improving glycemic control, thus potentially preserving renal function.
Sitagliptin, a DPP-4 inhibitor, may slow the progression of diabetic nephropathy by reducing albuminuria and improving glycemic control, thus potentially preserving renal function.
See lessCan Sitagliptin reduce fasting plasma glucose in severely obese diabetics?
Yes, Sitagliptin can effectively reduce fasting plasma glucose levels in severely obese diabetics, and it enhances insulin sensitivity by modulating incretin hormones.
Yes, Sitagliptin can effectively reduce fasting plasma glucose levels in severely obese diabetics, and it enhances insulin sensitivity by modulating incretin hormones.
See lessHow does Sitagliptin compare to GLP-1 receptor agonists in weight management?
Sitagliptin generally leads to less weight loss compared to GLP-1 receptor agonists, which often promote significant weight reduction in obese Type 2 diabetes patients.
Sitagliptin generally leads to less weight loss compared to GLP-1 receptor agonists, which often promote significant weight reduction in obese Type 2 diabetes patients.
See lessCan Sitagliptin improve glycemic control during acute illnesses?
Sitagliptin has not been specifically validated for managing acute hyperglycemia during illness or stress-related glucose spikes.
Sitagliptin has not been specifically validated for managing acute hyperglycemia during illness or stress-related glucose spikes.
See lessHow does Sitagliptin prevent weight loss in malnourished diabetics?
Sitagliptin stabilizes blood glucose by enhancing incretin hormones, which inhibit glucagon release and stimulate insulin secretion, thus improving nutrient utilization and supporting weight maintenance.
Sitagliptin stabilizes blood glucose by enhancing incretin hormones, which inhibit glucagon release and stimulate insulin secretion, thus improving nutrient utilization and supporting weight maintenance.
See less